Astrana Health Stock Analysis

ASTH Stock   44.81  1.56  3.61%   
Astrana Health is overvalued with Real Value of 41.86 and Target Price of 49.67. The main objective of Astrana Health stock analysis is to determine its intrinsic value, which is an estimate of what Astrana Health is worth, separate from its market price. There are two main types of Astrana Health's stock analysis: fundamental analysis and technical analysis.
The Astrana Health stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Astrana Health's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

Astrana Stock Analysis Notes

About 24.0% of the company shares are held by company insiders. The book value of Astrana Health was presently reported as 14.75. The company had not issued any dividends in recent years. Astrana Health had 1:10 split on the 27th of April 2015. For more info on Astrana Health please contact Brandon Sim at 626 282 0288 or go to https://www.astranahealth.com.

Astrana Health Quarterly Total Revenue

478.71 Million

Astrana Health Investment Alerts

Astrana Health generated a negative expected return over the last 90 days
Astrana Health has high historical volatility and very poor performance
Astrana Health is unlikely to experience financial distress in the next 2 years
Astrana Health was previously known as Astrana Health and was traded on NASDAQ Exchange under the symbol AMEH.
About 24.0% of the company shares are held by company insiders
Latest headline from simplywall.st: Disposition of 3409 shares by Kitayama Mitchell W of Astrana Health at 18.41 subject to Rule 16b-3

Astrana Largest EPS Surprises

Earnings surprises can significantly impact Astrana Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-03-12
2019-12-310.20.18-0.0210 
2023-08-07
2023-06-300.250.280.0312 
2023-02-23
2022-12-31-0.09-0.060.0333 
View All Earnings Estimates

Astrana Health Environmental, Social, and Governance (ESG) Scores

Astrana Health's ESG score is a quantitative measure that evaluates Astrana Health's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Astrana Health's operations that may have significant financial implications and affect Astrana Health's stock price as well as guide investors towards more socially responsible investments.

Astrana Stock Institutional Investors

Shares
Northern Trust Corp2024-09-30
424.1 K
Morgan Stanley - Brokerage Accounts2024-09-30
342.6 K
Fort Washington Investment Advisors Inc2024-09-30
299.8 K
Bank Of New York Mellon Corp2024-09-30
268.7 K
Goldman Sachs Group Inc2024-09-30
258.9 K
Royal Bank Of Canada2024-09-30
254.6 K
Bellevue Group Ag2024-09-30
254.2 K
Amvescap Plc.2024-09-30
241.8 K
Atria Wealth Solutions, Inc.2024-09-30
237.4 K
Blackrock Inc2024-06-30
6.4 M
Vanguard Group Inc2024-09-30
4.7 M
Note, although Astrana Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Astrana Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.05 B.

Astrana Profitablity

The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.10  0.11 
Return On Capital Employed 0.12  0.12 
Return On Assets 0.07  0.07 
Return On Equity 0.10  0.10 

Management Efficiency

Astrana Health has return on total asset (ROA) of 0.0449 % which means that it generated a profit of $0.0449 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1026 %, meaning that it created $0.1026 on every $100 dollars invested by stockholders. Astrana Health's management efficiency ratios could be used to measure how well Astrana Health manages its routine affairs as well as how well it operates its assets and liabilities. The Astrana Health's current Return On Tangible Assets is estimated to increase to 0.11. The Astrana Health's current Return On Capital Employed is estimated to increase to 0.12. As of now, Astrana Health's Non Currrent Assets Other are increasing as compared to previous years. The Astrana Health's current Other Current Assets is estimated to increase to about 18.3 M, while Other Assets are projected to decrease to under 12.9 M.
Last ReportedProjected for Next Year
Book Value Per Share 8.79  8.26 
Tangible Book Value Per Share 1.29  1.23 
Enterprise Value Over EBITDA 14.86  8.74 
Price Book Value Ratio 2.95  4.22 
Enterprise Value Multiple 14.86  8.74 
Price Fair Value 2.95  4.22 
Enterprise Value1.8 BB
Understanding the operational decisions made by Astrana Health management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Operating Margin
0.0594
Profit Margin
0.0363
Beta
1.238
Return On Assets
0.0449
Return On Equity
0.1026

Technical Drivers

As of the 3rd of December, Astrana Health shows the Mean Deviation of 1.99, standard deviation of 3.52, and Risk Adjusted Performance of 0.0027. Astrana Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Astrana Health Price Movement Analysis

Execute Study
The output start index for this execution was twenty-seven with a total number of output elements of thirty-four. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Astrana Health middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Astrana Health. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Astrana Health Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Astrana Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Astrana Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Astrana Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Astrana Health Outstanding Bonds

Astrana Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Astrana Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Astrana bonds can be classified according to their maturity, which is the date when Astrana Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Astrana Health Predictive Daily Indicators

Astrana Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Astrana Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Astrana Health Corporate Filings

F4
26th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
20th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
14th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
13th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10Q
12th of November 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
8K
8th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
7th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
7th of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Astrana Health Forecast Models

Astrana Health's time-series forecasting models are one of many Astrana Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Astrana Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Astrana Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Astrana Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Astrana shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Astrana Health. By using and applying Astrana Stock analysis, traders can create a robust methodology for identifying Astrana entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.06  0.04 
Operating Profit Margin 0.06  0.05 
Net Profit Margin 0.04  0.05 
Gross Profit Margin 0.16  0.20 

Current Astrana Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Astrana analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Astrana analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
49.67Strong Buy11Odds
Astrana Health current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Astrana analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Astrana stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Astrana Health, talking to its executives and customers, or listening to Astrana conference calls.
Astrana Analyst Advice Details

Astrana Stock Analysis Indicators

Astrana Health stock analysis indicators help investors evaluate how Astrana Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Astrana Health shares will generate the highest return on investment. By understating and applying Astrana Health stock analysis, traders can identify Astrana Health position entry and exit signals to maximize returns.
Begin Period Cash Flow288 M
Long Term Debt258.9 M
Common Stock Shares Outstanding47.1 M
Total Stockholder Equity614.2 M
Tax Provision32 M
Quarterly Earnings Growth Y O Y-0.298
Property Plant And Equipment Net44.6 M
Cash And Short Term Investments296.3 M
Cash293.8 M
Accounts Payable9.1 M
Net Debt27.2 M
50 Day M A53.075
Total Current Liabilities218.7 M
Other Operating Expenses1.3 B
Non Current Assets Total471.9 M
Non Currrent Assets Other44.6 M
Stock Based Compensation22 M

Complementary Tools for Astrana Stock analysis

When running Astrana Health's price analysis, check to measure Astrana Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astrana Health is operating at the current time. Most of Astrana Health's value examination focuses on studying past and present price action to predict the probability of Astrana Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astrana Health's price. Additionally, you may evaluate how the addition of Astrana Health to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA